Home

Telemacos Arashigaoka Mancare sanatoasa cd 147 a văzut Necinste rezervor

CD147‑mediated reprogrammed glycolytic metabolism potentially induces immune escape in the tumor microenvironment (Review)
CD147‑mediated reprogrammed glycolytic metabolism potentially induces immune escape in the tumor microenvironment (Review)

CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells | Signal Transduction and Targeted Therapy
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells | Signal Transduction and Targeted Therapy

CD147 Monoclonal Antibody (RL73), Functional Grade (16-1471-82)
CD147 Monoclonal Antibody (RL73), Functional Grade (16-1471-82)

CD147 deficiency in T cells prevents thymic involution by inhibiting the EMT process in TECs in the presence of TGFβ | Cellular & Molecular Immunology
CD147 deficiency in T cells prevents thymic involution by inhibiting the EMT process in TECs in the presence of TGFβ | Cellular & Molecular Immunology

CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement | SpringerLink
CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement | SpringerLink

Cancers | Free Full-Text | CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker
Cancers | Free Full-Text | CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker

IHCeasy CD147/BSG Ready-To-Use IHC Kit KHC0607 | Proteintech
IHCeasy CD147/BSG Ready-To-Use IHC Kit KHC0607 | Proteintech

CD147‑mediated reprogrammed glycolytic metabolism potentially induces immune escape in the tumor microenvironment (Review)
CD147‑mediated reprogrammed glycolytic metabolism potentially induces immune escape in the tumor microenvironment (Review)

YIPF2 is a novel Rab-GDF that enhances HCC malignant phenotypes by facilitating CD147 endocytic recycle | Cell Death & Disease
YIPF2 is a novel Rab-GDF that enhances HCC malignant phenotypes by facilitating CD147 endocytic recycle | Cell Death & Disease

Frontiers | Generation of a High-Affinity Nanobody Against CD147 for Tumor Targeting and Therapeutic Efficacy Through Conjugating Doxorubicin
Frontiers | Generation of a High-Affinity Nanobody Against CD147 for Tumor Targeting and Therapeutic Efficacy Through Conjugating Doxorubicin

IJMS | Free Full-Text | The Biological Function and Clinical Utilization of CD147 in Human Diseases: A Review of the Current Scientific Literature
IJMS | Free Full-Text | The Biological Function and Clinical Utilization of CD147 in Human Diseases: A Review of the Current Scientific Literature

IHCeasy CD147/BSG Ready-To-Use IHC Kit KHC0607 | Proteintech
IHCeasy CD147/BSG Ready-To-Use IHC Kit KHC0607 | Proteintech

The Roles of CD147 and/or Cyclophilin A in Kidney Diseases
The Roles of CD147 and/or Cyclophilin A in Kidney Diseases

A novel mouse model to test SARS-CoV-2 viral infection
A novel mouse model to test SARS-CoV-2 viral infection

CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis | Scientific Reports
CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis | Scientific Reports

IHCeasy CD147/BSG Ready-To-Use IHC Kit KHC0607 | Proteintech
IHCeasy CD147/BSG Ready-To-Use IHC Kit KHC0607 | Proteintech

Cells | Free Full-Text | SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2
Cells | Free Full-Text | SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2

Cancers | Free Full-Text | CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker
Cancers | Free Full-Text | CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker

Research that shows Interaction of SARS-Cov-2 Spike Protein to CD147 in COVID-19 Associated Lymphopenia
Research that shows Interaction of SARS-Cov-2 Spike Protein to CD147 in COVID-19 Associated Lymphopenia

IJMS | Free Full-Text | The Multiple Roles of CD147 in the Development and Progression of Oral Squamous Cell Carcinoma: An Overview
IJMS | Free Full-Text | The Multiple Roles of CD147 in the Development and Progression of Oral Squamous Cell Carcinoma: An Overview

CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target - ScienceDirect
CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target - ScienceDirect

Recombinant Anti-CD147 antibody [EPR4053] KO Tested (ab108308) | Abcam
Recombinant Anti-CD147 antibody [EPR4053] KO Tested (ab108308) | Abcam

Enhanced susceptibility of SARS-CoV-2 spike RBD protein assay targeted by cellular receptors ACE2 and CD147: multivariate data analysis of multisine impedimetric response | Analytical Chemistry | ChemRxiv | Cambridge Open Engage
Enhanced susceptibility of SARS-CoV-2 spike RBD protein assay targeted by cellular receptors ACE2 and CD147: multivariate data analysis of multisine impedimetric response | Analytical Chemistry | ChemRxiv | Cambridge Open Engage